Immunome Newsroom

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Futu NewsSep 16 20:31

TD Cowen Sticks to Its Buy Rating for Immunome (IMNM)

TipRanksSep 16 19:49

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Futu NewsAug 14 20:34

Leerink Partners Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $38

Futu NewsAug 13 22:32

Buy Rating Affirmed on Immunome: Promising Clinical Trials and Strategic Growth Prospects

TipRanksAug 13 22:23

Wedbush Reiterates Outperform on Immunome, Maintains $33 Price Target

BenzingaAug 13 21:07

Immunome Price Target Cut to $23.00/Share From $27.00 by Piper Sandler

Dow JonesAug 13 19:36

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Futu NewsAug 13 19:31

Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Cuts Target Price to $23

Futu NewsAug 13 19:31

Immunome Analyst Ratings

BenzingaAug 13 19:27

Piper Sandler Sticks to Their Buy Rating for Immunome (IMNM)

TipRanksAug 13 18:58

TD Cowen Sticks to Its Buy Rating for Immunome (IMNM)

TipRanksAug 13 08:39

Immunome (IMNM.US) was first covered by Piper Sandler, which gave it an increase rating, and the target price was $27.00.

Zhitong FinanceMay 31 18:02

Immunome Analyst Ratings

BenzingaMay 31 18:00

Piper Sandler Initiates Coverage On Immunome With Overweight Rating, Announces Price Target of $27

BenzingaMay 31 18:00

Immunome's Promising Pipeline and Strategic Positioning Affirm Buy Rating

TipRanksMay 16 16:20

TD Cowen Sticks to Their Buy Rating for Immunome (IMNM)

TipRanksMay 13 20:11

Immunome Analyst Ratings

BenzingaApr 30 20:45

JPMorgan Starts Immunome With Overweight Rating, $24 Price Target

MT NewswiresApr 30 19:31

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Dyne Therapeutics (DYN) and Dexcom (DXCM)

TipRanksApr 30 17:05